Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Oda N, Miyahara N, Ichikawa H, Tanimoto Y, Kajimoto K, Sakugawa M, Kawai H, Taniguchi A, Morichika D, Tanimoto M, Kanehiro A, Kiura K. Oda N, et al. Among authors: sakugawa m. Int J Chron Obstruct Pulmon Dis. 2017 Apr 10;12:1119-1124. doi: 10.2147/COPD.S133071. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28435245 Free PMC article.
[Case of pulmonary Langerhans-cell histiocytosis].
Sakugawa M, Tanimoto Y, Miyahara N, Kanehiro A, Kataoka M, Tanimoto M, Date H, Shimizu N, Yamadori I, Shibayama T. Sakugawa M, et al. Nihon Naika Gakkai Zasshi. 2002 Sep 10;91(9):2765-7. doi: 10.2169/naika.91.2765. Nihon Naika Gakkai Zasshi. 2002. PMID: 12373903 Japanese. No abstract available.
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY).
Ninomiya K, Hata T, Yoshioka H, Ohashi K, Bessho A, Hosokawa S, Ishikawa N, Yamasaki M, Shibayama T, Aoe K, Kozuki T, Harita S, Ueda Y, Murakami T, Fujimoto N, Yanai H, Toyooka S, Takata M, Hotta K, Kiura K; HER2-CS Network. Ninomiya K, et al. Chest. 2019 Aug;156(2):357-366. doi: 10.1016/j.chest.2019.01.011. Epub 2019 May 6. Chest. 2019. PMID: 31072612
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Ninomiya T, Nogami N, Kozuki T, Harada D, Kubo T, Ohashi K, Ichihara E, Kuyama S, Kudo K, Bessho A, Sakugawa M, Fujimoto N, Aoe K, Minami D, Sugimoto K, Ochi N, Takigawa N, Hotta K, Maeda Y, Kiura K. Ninomiya T, et al. Among authors: sakugawa m. Jpn J Clin Oncol. 2021 Aug 1;51(8):1269-1276. doi: 10.1093/jjco/hyab084. Jpn J Clin Oncol. 2021. PMID: 34115855 Clinical Trial.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Nogami N, Kubo T, Bessho A, Sakugawa M, Ikeo S, Yokoyama T, Seki N, Ochiai R, Fujimoto N, Murakami S, Kaira K, Harada T, Kishino D, Takiguchi Y, Shimokawa T, Kiura K, Yamashita N, Okamoto H. Nogami N, et al. Among authors: sakugawa m. Jpn J Clin Oncol. 2024 Jul 7;54(7):805-812. doi: 10.1093/jjco/hyae044. Jpn J Clin Oncol. 2024. PMID: 38594880 Free PMC article. Clinical Trial.
24 results